Barat, S., Borroto-Esoda, K., Ghannoum, M., Berkow, E., & Angulo, D. A. (2019). 672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida auris: In vitro, In Vivo, and Clinical Case Studies of Candidemia. Open Forum Infectious Diseases, 6, S307. https://doi.org/10.1093/ofid/ofz360.740
Chicago Style (17th ed.) CitationBarat, Stephen, Katyna Borroto-Esoda, Mahmoud Ghannoum, Elizabeth Berkow, and David A. Angulo. "672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida Auris: In Vitro, In Vivo, and Clinical Case Studies of Candidemia." Open Forum Infectious Diseases 6 (2019): S307. https://doi.org/10.1093/ofid/ofz360.740.
MLA (9th ed.) CitationBarat, Stephen, et al. "672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida Auris: In Vitro, In Vivo, and Clinical Case Studies of Candidemia." Open Forum Infectious Diseases, vol. 6, 2019, p. S307, https://doi.org/10.1093/ofid/ofz360.740.